HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ritobegron

Also Known As:

2-(4-(2-((2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)-2,5-dimethylphenyloxy)acetic acid; KUC-7322

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Ethylamines: 5
    - Phenethylamines: 28
      - Amphetamines: 717
        p-Hydroxyamphetamine: 44
        ritobegron: 4
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acetates: 4994
      - ritobegron: 4
Lipids: 114793
- Fatty Acids: 27405
  - Volatile Fatty Acids: 3052
    - Acetates: 4994
      - ritobegron: 4

Experts

1.	Hoyano, Yuji: 3 articles (08/2012 - 01/2012)
2.	Kusama, Hiroshi: 3 articles (08/2012 - 01/2012)
3.	Maruyama, Itaru: 3 articles (08/2012 - 01/2012)
4.	Maruyama, Kazuyasu: 3 articles (08/2012 - 01/2012)
5.	Tatemichi, Satoshi: 3 articles (08/2012 - 01/2012)
6.	Yamazaki, Yoshinobu: 3 articles (08/2012 - 01/2012)
7.	Goi, Yoshiaki: 2 articles (08/2012 - 07/2012)
8.	Igawa, Yasuhiko: 1 article (03/2013)
9.	Michel, Martin C: 1 article (03/2013)
10.	Yonekubo, Saori: 1 article (01/2012)

Related Diseases

1.	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/01/2012 - "The objective of this study was to investigate the effects of the β3-adrenoceptor (AR) agonist ritobegron on rat bladder function following partial bladder outlet obstruction and on rat salivary secretion. " 01/01/2012 - "Effects of ritobegron (KUC-7483), a novel β3-adrenoceptor agonist, on both rat bladder function following partial bladder outlet obstruction and on rat salivary secretion: a comparison with the effects of tolterodine."
2.	Overactive Urinary Bladder (Overactive Bladder) 08/01/2012 - "These results suggest that ritobegron shows promise as a potential agent for the treatment of overactive bladder." 07/01/2012 - "These results suggest that ritobegron may be a promising potential agent for the treatment of overactive bladder." 01/01/2012 - "Ritobegron decreased both the frequency and amplitude of NVC, which is similar to its effect on the contractions associated with detrusor overactivity (DO) in patients with an overactive bladder (OAB), without affecting MP, RV, or CCh-induced salivary secretion. " 03/01/2013 - "β(3)-Adrenoceptor agonists are an emerging drug class for the treatment of the overactive bladder syndrome, and clinical proof-of-concept data have been obtained for three representatives of this class, mirabegron, ritobegron, and solabegron. "

Related Drugs and Biologics

1.	Tolterodine Tartrate (Detrol)
2.	solabegron
3.	mirabegron